SARS-CoV-2 seroprevalence in French 9-year-old children and their parents after the first lockdown in 2020

Marie‐Aline Charles, Pierre‐Yves Ancel, Thierry Siméon, Laetitia Marchand‐Martin, Cécile Zaros, Marie‐Noëlle Dufourg, Valérie Benhamou, Hélène Blanché, Jean‐François Deleuze, Delphine Rahib, Nathalie Lydié, Xavier de Lamballerie, Fabrice CarratFrontiers in Pediatrics 2023 · DOI

Abstract

We have shown that 9-yr old children had a lower susceptibility to SARS-Cov2 infection than adults with the initial Chinese strain, similar to younger children and estimated that around 3% of them have developed antibodies against SARS-Cov2 in France after the first wave of the Covid-19 epidemics.

Introduction

Early in the COVID-19 pandemic, it became clear that children were less likely to suffer severe illness than adults. However, data regarding the specific susceptibility of children as they approach adolescence (10+ years) remained sparse. Most early studies grouped broad age ranges together, making it difficult to discern when infection patterns begin to mirror those of adults. This study addresses this gap by analyzing a large, representative sample of French 9-year-olds to determine their seroprevalence and how it relates to household exposure following the initial 2020 lockdown.

Methods

The researchers leveraged two existing French nationwide longitudinal cohorts: Elfe (children born at term or late preterm in 2011) and Epipage2 (children born extremely preterm in 2011). These cohorts were part of the SAPRIS project, established to investigate the impact of the pandemic.

In April and May 2020, families completed online questionnaires regarding symptoms and household life. Participants then used Dried Blood Spot (DBS) kits for home capillary blood collection. These samples were analyzed using a commercial ELISA test (Euroimmun®) to detect IgG antibodies against the S1 domain of the SARS-CoV-2 spike protein. Results were statistically weighted to ensure the data represented the broader French population of children born in 2011.

Results

Seroprevalence and Regional Variation

The weighted seroprevalence for 9-year-old children was 2.8% (95% CI: 1.7%–4.0%), which was significantly lower than the 8.6% (95% CI: 7.4%–9.7%) found in their parents. This confirms that at age 9, children still exhibited lower susceptibility to the original SARS-CoV-2 strain compared to adults. Seroprevalence followed a clear geographical gradient, with the highest rates in the Grand Est region and the lowest in Nouvelle Aquitaine.

Table showing seroprevalence of SARS-CoV-2 in children and parents by region

Symptom Correlation and Household Transmission

A striking 74% of seropositive children reported no symptoms during the lockdown period, confirming that infection in this age group is frequently "silent." While specific symptoms like anosmia (loss of smell), ageusia (loss of taste), and fever were significantly associated with positive serology, clinical symptoms overall were poor predictors of infection due to the high rate of asymptomatic cases.

Table detailing the prevalence of various symptoms by serology status

Household transmission was the strongest predictor of a child's infection status. Having a seropositive parent in the same house increased the odds of a child being seropositive by 13.8 times. However, even when a parent was infected, only about 14% of children in those households tested positive, reinforcing the finding of lower susceptibility in this age group.

Discussion and Limitations

The study suggests that the transition to adult-like infection patterns likely occurs later in puberty or adolescence. A key limitation is that the use of DBS and ELISA tests may have lower sensitivity than venous blood draws, potentially underestimating true infection rates. Additionally, these results reflect the "initial Chinese strain"; later variants like Delta and Omicron showed significantly higher transmission rates among children. Future research into the robust innate immune response in children may explain why many do not develop detectable antibodies even after exposure.

Summary updated

Abstract

We have shown that 9-yr old children had a lower susceptibility to SARS-Cov2 infection than adults with the initial Chinese strain, similar to younger children and estimated that around 3% of them have developed antibodies against SARS-Cov2 in France after the first wave of the Covid-19 epidemics.
BibTeX
@inproceedings{charles2023sars,
  author = {Marie‐Aline Charles and Pierre‐Yves Ancel and Thierry Siméon and Laetitia Marchand‐Martin and Cécile Zaros and Marie‐Noëlle Dufourg and Valérie Benhamou and Hélène Blanché and Jean‐François Deleuze and Delphine Rahib and Nathalie Lydié and Xavier de Lamballerie and Fabrice Carrat},
  title = {{SARS-CoV-2 seroprevalence in French 9-year-old children and their parents after the first lockdown in 2020}},
  booktitle = {Frontiers in Pediatrics},
  year = {2023},
  doi = {10.3389/fped.2023.1274113},
}
Figure